Send feedback

MANBA p.Val771Phe

c.2311G>T · rs201779762 · VCV347082

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.2325 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00133%, afr)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
beta-mannosidosis

Computational evidence

Protein change
AlphaMissense0.2325likely benign
REVEL0.087moderately benign-leaning
SaProtLLR -8.99tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAIΔ0.32acceptor gain · deltas
PangolinΔ0.21gain · loss 0.00 · agrees with SpliceAI · independent
Constraint at this position
ConservationphyloP -1.1GERP -4.9
Regional constrainto/e 0.97unconstrained · MANE · 129 kb · p 0.31 · regional, not allelic
Overall
CADD12.55PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00133% African / African-American · 1/74,916 alleles
Filtering AF 0.000615% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000474%
Overall 0.00781% 126/1,614,096 alleles · very rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.317% 315
Remaining individualsnot grpmax-eligible 0.0272% 3,676
African / African-Americangrpmax 0.00133% 74,916
European (non-Finnish) 0.0011% 90,774
South Asian 0.0011% 91,090

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MANBA
Protein
p.Val771Phe
Coding
c.2311G>T
MANE Select
NM_005908
dbSNP
rs201779762
Type
single nucleotide variant
Location
chr4:102634892 (GRCh38)
Gene constraint
LOEUF 0.826 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 96.05
Residue 771
a UniProt-annotated variant site (in mansb; complete loss of enzyme activity)
Full MANBA gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

beta-mannosidosis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Beta-mannosidosis (Orphanet):

Inheritance
Autosomal recessive
Onset
Adolescent, Adult, Childhood, Infancy, Neonatal
Prevalence
1-9 / 1 000 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/manba-p-val771phe (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown